Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

OncoTherapy Science presents phase II results for OTS-102 in biliary tract cancer

Oct. 11, 2013

Molecular Templates raises funds to advance MT-3724

Oct. 10, 2013

Development of a targeted immunotoxin for the destruction of brain cancer cells in glioblastomas

Oct. 9, 2013

Immutep and Eddingpharm sign agreement for ImmuFact IMP-321 in China

Oct. 8, 2013

Kitasato Institute and Tella to collaborate on dendritic cell vaccine study

Oct. 8, 2013

MorphoSys completes phase I/IIa study of MOR-208 in CLL

Oct. 7, 2013

European submission to broaden label for Arzerra to include first-line CLL

Oct. 7, 2013

Heat Biologics files IND for HS-410 in bladder cancer

Oct. 3, 2013

Scancell provides update on its drug discovery pipeline

Oct. 3, 2013

Phase I/II trial of Mologen's renal cancer vaccine meets primary endpoints

Oct. 2, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...